These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20329583)

  • 21. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells.
    Berdyshev EV; Schmid PC; Krebsbach RJ; Schmid HH
    FASEB J; 2001 Oct; 15(12):2171-8. PubMed ID: 11641243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The endocannabinoid 2-arachidonylglycerol is a negative allosteric modulator of the human A3 adenosine receptor.
    Lane JR; Beukers MW; Mulder-Krieger T; Ijzerman AP
    Biochem Pharmacol; 2010 Jan; 79(1):48-56. PubMed ID: 19665453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Key questions of endocannabinoid signalling in the CNS: which, where and when?
    Frazier CJ
    J Physiol; 2011 Oct; 589(Pt 20):4807-8. PubMed ID: 22001725
    [No Abstract]   [Full Text] [Related]  

  • 24. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
    Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
    Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of the endocannabinoid system in periodontal healing.
    Kozono S; Matsuyama T; Biwasa KK; Kawahara K; Nakajima Y; Yoshimoto T; Yonamine Y; Kadomatsu H; Tancharoen S; Hashiguchi T; Noguchi K; Maruyama I
    Biochem Biophys Res Commun; 2010 Apr; 394(4):928-33. PubMed ID: 20233580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.
    Maccarrone M; Finazzi-Agró A
    Cell Death Differ; 2003 Sep; 10(9):946-55. PubMed ID: 12934069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Importance of the endocannabinoid system in the regulation of energy homeostasis].
    Kvasnicka T
    Vnitr Lek; 2008 Feb; 54(2):191-4. PubMed ID: 23687711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Arachidonoylglycerol enhances platelet formation from human megakaryoblasts.
    Gasperi V; Avigliano L; Evangelista D; Oddi S; Chiurchiù V; Lanuti M; Maccarrone M; Valeria Catani M
    Cell Cycle; 2014; 13(24):3938-47. PubMed ID: 25427281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
    Sugiura T; Kishimoto S; Oka S; Gokoh M
    Prog Lipid Res; 2006 Sep; 45(5):405-46. PubMed ID: 16678907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area.
    Mátyás F; Urbán GM; Watanabe M; Mackie K; Zimmer A; Freund TF; Katona I
    Neuropharmacology; 2008 Jan; 54(1):95-107. PubMed ID: 17655884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocannabinoid identification in the brain: studies of breakdown lead to breakthrough, and there may be NO hope.
    Alger BE
    Sci STKE; 2005 Nov; 2005(309):pe51. PubMed ID: 16278487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know.
    Alger BE
    J Physiol; 2012 May; 590(10):2203-12. PubMed ID: 22289914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease.
    van der Stelt M; Fox SH; Hill M; Crossman AR; Petrosino S; Di Marzo V; Brotchie JM
    FASEB J; 2005 Jul; 19(9):1140-2. PubMed ID: 15894565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice.
    Avraham Y; Israeli E; Gabbay E; Okun A; Zolotarev O; Silberman I; Ganzburg V; Dagon Y; Magen I; Vorobia L; Pappo O; Mechoulam R; Ilan Y; Berry EM
    Neurobiol Dis; 2006 Jan; 21(1):237-45. PubMed ID: 16102970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal.
    Pryor SR
    Med Hypotheses; 2000 Dec; 55(6):494-501. PubMed ID: 11090297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor.
    He F; Qiao ZH; Cai J; Pierce W; He DC; Song ZH
    Mol Pharmacol; 2007 Nov; 72(5):1289-300. PubMed ID: 17698952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.
    Di Marzo V
    Pharmacol Res; 2009 Aug; 60(2):77-84. PubMed ID: 19559360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.